연구동향 분석

Lipoprotein-Associated Phospholipase A2 Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome

정혜문 이병권 권혁문 김종윤 윤영원 이지혁 최의영 민필기 홍범기 임세중 윤지현 이성주 박종관 김명현 조민희 양정희 2014년

논문상세정보
인용/피인용
' Lipoprotein-Associated Phospholipase A2 Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • acute coronary syndrome
  • biomarker
  • coronaryatheroscleroticplaqueinstability
  • lp-pla2
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,861 0

0.0%

' Lipoprotein-Associated Phospholipase A2 Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome' 의 참고문헌

  • Unstable angina. A classification
    Braunwald E Circulation 80 : 410 ~ 414 [1989]
  • Unstable angina. A classification
    Braunwald E Circulation 80 410-414 [1989]
  • The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
    Tellis CC Biochim Biophys Acta 1791 : 327 ~ 338 [2009]
  • The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
    Tellis CC Biochim Biophys Acta 1791 327-338 [2009]
  • The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study
    Mohler ER 3rd J Am Coll Cardiol 51 : 1632 ~ 1641 [2008]
  • The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study
    Mohler ER 3rd J Am Coll Cardiol 51 1632-1641 [2008]
  • The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease
    서홍석 Korean Circulation Journal 42 (3) : 151 ~ 153 [2012]
  • The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease
    서홍석 Korean Circulation Journal 42 3 151-153 [2012]
  • The Risk of Metabolic Syndrome According to the White Blood Cell Count in Apparently Healthy Korean Adults
    정찬희 Yonsei Medical Journal 54 (3) : 615 ~ 620 [2013]
  • The Risk of Metabolic Syndrome According to the White Blood Cell Count in Apparently Healthy Korean Adults
    정찬희 Yonsei Medical Journal 54 3 615-620 [2013]
  • Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
    White H Am Heart J 160 : 655 ~ 661 [2010]
  • Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
    White H Am Heart J 160 655-661 [2010]
  • Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
    O’Donoghue ML Am Heart J 162 : 613 ~ 619 [2011]
  • Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
    O’Donoghue ML Am Heart J 162 613-619 [2011]
  • Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I Isr Med Assoc J 10 : 494 ~ 498 [2008]
  • Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I Isr Med Assoc J 10 494-498 [2008]
  • Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target
    Zalewski A Arterioscler Thromb Vasc Biol 25 : 923 ~ 931 [2005]
  • Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target
    Zalewski A Arterioscler Thromb Vasc Biol 25 923-931 [2005]
  • Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins
    Tew DG Arterioscler Thromb Vasc Biol 16 : 591 ~ 599 [1996]
  • Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins
    Tew DG Arterioscler Thromb Vasc Biol 16 591-599 [1996]
  • Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes
    Ryu SK Circulation 125 : 757 ~ 766 [2012]
  • Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes
    Ryu SK Circulation 125 757-766 [2012]
  • Phospholipase A2 enzymes and the risk of atherosclerosis
    Rosenson RS Eur Heart J 33 : 2899 ~ 2909 [2012]
  • Phospholipase A2 enzymes and the risk of atherosclerosis
    Rosenson RS Eur Heart J 33 2899-2909 [2012]
  • Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin
    Owens AP 3rd J Clin Invest 122 : 558 ~ 568 [2012]
  • Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin
    Owens AP 3rd J Clin Invest 122 558-568 [2012]
  • Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein
    Stafforini DM J Biol Chem 274 : 7018 ~ 7024 [1999]
  • Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein
    Stafforini DM J Biol Chem 274 7018-7024 [1999]
  • Markers of inflammation and coronary artery calcification: a systematic review
    Hamirani YS Atherosclerosis 201 : 1 ~ 7 [2008]
  • Markers of inflammation and coronary artery calcification: a systematic review
    Hamirani YS Atherosclerosis 201 1-7 [2008]
  • Lp-PLA2: an emerging biomarker of coronary heart disease
    Dada N Expert Rev Mol Diagn 2 : 17 ~ 22 [2002]
  • Lp-PLA2: an emerging biomarker of coronary heart disease
    Dada N Expert Rev Mol Diagn 2 17-22 [2002]
  • Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery disease
    Epps KC J Intern Med 269 : 94 ~ 106 [2011]
  • Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery disease
    Epps KC J Intern Med 269 94-106 [2011]
  • Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
    Ballantyne CM Circulation 109 : 837 ~ 842 [2004]
  • Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
    Ballantyne CM Circulation 109 837-842 [2004]
  • Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
    Kolodgie FD Arterioscler Thromb Vasc Biol 26 : 2523 ~ 2529 [2006]
  • Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
    Kolodgie FD Arterioscler Thromb Vasc Biol 26 2523-2529 [2006]
  • Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target
    Packard CJ Curr Opin Cardiol 24 : 358 ~ 363 [2009]
  • Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target
    Packard CJ Curr Opin Cardiol 24 358-363 [2009]
  • Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany
    Koenig W Circulation 110 : 1903 ~ 1908 [2004]
  • Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany
    Koenig W Circulation 110 1903-1908 [2004]
  • Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
    Caslake MJ Curr Opin Lipidol 14 : 347 ~ 352 [2003]
  • Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
    Caslake MJ Curr Opin Lipidol 14 347-352 [2003]
  • Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions
    Häkkinen T Arterioscler Thromb Vasc Biol 19 : 2909 ~ 2917 [1999]
  • Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions
    Häkkinen T Arterioscler Thromb Vasc Biol 19 2909-2917 [1999]
  • Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
    Caslake MJ Atherosclerosis 210 : 28 ~ 34 [2010]
  • Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
    Caslake MJ Atherosclerosis 210 28-34 [2010]
  • Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
    Lp-PLA(2) Studies Collaboration Lancet 375 : 1536 ~ 1544 [2010]
  • Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
    Lp-PLA(2) Studies Collaboration Lancet 375 1536-1544 [2010]
  • Lipoprotein-associated phospholipase A(2) and atherosclerosis
    Wilensky RL Curr Opin Lipidol 20 : 415 ~ 420 [2009]
  • Lipoprotein-associated phospholipase A(2) and atherosclerosis
    Wilensky RL Curr Opin Lipidol 20 415-420 [2009]
  • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
    Wilensky RL Nat Med 14 : 1059 ~ 1066 [2008]
  • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
    Wilensky RL Nat Med 14 1059-1066 [2008]
  • Heart disease and stroke statistics--2010 update: a report from the American Heart Association
    WRITING GROUP MEMBERS Circulation 121 : e46 ~ e215 [2010]
  • Heart disease and stroke statistics--2010 update: a report from the American Heart Association
    WRITING GROUP MEMBERS Circulation 121 e46-e215 [2010]
  • Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
    Pencina MJ Stat Med 27 : 157 ~ 172 [2008]
  • Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
    Pencina MJ Stat Med 27 157-172 [2008]
  • Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
    Mannheim D Stroke 39 : 1448 ~ 1455 [2008]
  • Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques
    Mannheim D Stroke 39 1448-1455 [2008]
  • Elevated plasma lipoprotein-associated phospholipase A2 activity is associated with plaque rupture in patients with coronary artery disease
    Liu CF Chin Med J (Engl) 124 : 2469 ~ 2473 [2011]
  • Elevated plasma lipoprotein-associated phospholipase A2 activity is associated with plaque rupture in patients with coronary artery disease
    Liu CF Chin Med J (Engl) 124 2469-2473 [2011]
  • Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    Serruys PW Circulation 118 : 1172 ~ 1182 [2008]
  • Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    Serruys PW Circulation 118 1172-1182 [2008]
  • Effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity in Japanese dyslipidemic patients, with exploratory analysis of a PLA2G7 gene polymorphism of Val279Phe
    Daida H Circ J 77 : 1518 ~ 1525 [2013]
  • Effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity in Japanese dyslipidemic patients, with exploratory analysis of a PLA2G7 gene polymorphism of Val279Phe
    Daida H Circ J 77 1518-1525 [2013]
  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    Hamm CW Eur Heart J 32 : 2999 ~ 3054 [2011]
  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    Hamm CW Eur Heart J 32 2999-3054 [2011]
  • Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    Davidson MH Am J Cardiol 101 : 51F ~ 57F [2008]
  • Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    Davidson MH Am J Cardiol 101 51F-57F [2008]
  • Association of inflammatory markers with angiographic severity and extent of coronary artery disease
    Drakopoulou M Atherosclerosis 206 : 335 ~ 339 [2009]
  • Association of inflammatory markers with angiographic severity and extent of coronary artery disease
    Drakopoulou M Atherosclerosis 206 335-339 [2009]
  • Association of Lipoprotein-Associated Phospholipase A_2 with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
    Yu-Sheng Liu Yonsei Medical Journal 52 (6) : 914 ~ 922 [2011]
  • Association of Lipoprotein-Associated Phospholipase A_2 with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
    Yu-Sheng Liu Yonsei Medical Journal 52 6 914-922 [2011]
  • Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures
    Cook NR Ann Intern Med 150 : 795 ~ 802 [2009]
  • Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures
    Cook NR Ann Intern Med 150 795-802 [2009]
  • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
    Anderson JL Circulation 116 e148-e304 [2007]
  • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
    Anderson JL Circulation 116 : e148 ~ e304 [2007]
  • A classification of unstable angina revisited
    Hamm CW Circulation 102 : 118 ~ 122 [2000]
  • A classification of unstable angina revisited
    Hamm CW Circulation 102 118-122 [2000]